OptimizeRx Gets Analyst Pickup

ROCHESTER — OptimizeRx Corp. (OTC: OPRX) said San Francisco, Calif.-based Merriman Capital has initiated coverage on the company’s stock, with a buy rating and a price target of $3. Merriman …